Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Alvotech (ALVO) has a market cap of $2.60 billion USD. According to our data, Alvotech is ranked No.3569 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $2.60 B |
-35.03%
|
| Dec 31, 2024 | $3.99 B |
15.24%
|
| Dec 29, 2023 | $3.47 B |
14.80%
|
| Dec 30, 2022 | $3.02 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
| Market Cap | = | ALVO Stock Price | * | ALVO Shares Outstanding |
| = | $8.60 | * | 0.30 B | |
| = | $2.60 B |